Logo Keiran Smalley Lab
  • Home
  • Research
  • Lab Members
  • News

News

  • Home
  • Research
  • Lab Members
  • News

2020

  • September 2nd Press release: our recent publication in Journal of Investigative Dermatology where we identified non-canonical EphA2 signaling is a driver of the BRAF inhibitor-resistant melanoma
  • January 10th  Press release: our recent publication in Clinical Cancer Research where we analyzed protein expression markers in CSF from patients with leptomeningeal disease

2019

  • October 8th Press release: using an adaptive dosing schedule for BRAFi therapy prolongs drug sensitivity in melanoma by maintaining diverse tumor cell populations
  • July 8th Press release: our publication in Clinical Cancer Research where preclinical studies reveal the impact of HDAC inhibitors in uveal melanoma

 

 

smalley   News
©Copyright 2023. All rights reserved. Sitemap Read about privacy Read our terms